ArticleHemaSphere2022

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.

Verena Petzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.